How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/chloroquine-resistant-plasmodium-falciparum-malaria-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Malarone	PROGUANIL	GSK	Antimalarial [EPC]		2000-01-01
Vibramycin	doxycycline	Generic (originally Pfizer)	Tetracycline antibiotic	72 kDa type IV collagenase, Stromelysin-1, Collagenase 3	1967-01-01
Doxycyclin	Doxycyclin	Bulovka Hospital		72 kDa type IV collagenase, Stromelysin-1, Collagenase 3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 4 drugs in Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention
Bulovka Hospital · 1 drug in Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention
GSK · 1 drug in Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention
Generic (originally Pfizer) · 1 drug in Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention:

Cite this brief

Drug Landscape (2026). Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chloroquine-resistant-plasmodium-falciparum-malaria-prevention. Accessed 2026-06-10.

Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing